{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:33:40Z","timestamp":1785447220773,"version":"3.56.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000052","name":"HHS | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["U54OD030167"],"award-info":[{"award-number":["U54OD030167"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"HHS | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS140497"],"award-info":[{"award-number":["R21NS140497"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"HHS | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08-NS120812"],"award-info":[{"award-number":["K08-NS120812"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["MD240021"],"award-info":[{"award-number":["MD240021"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"DOI":"10.1038\/s44321-025-00271-x","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:03:00Z","timestamp":1753232580000},"page":"1893-1895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["miR-33 inhibition as a novel therapeutic approach for treating muscular dystrophy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3029-0761","authenticated-orcid":false,"given":"Michael A","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-5171","authenticated-orcid":false,"given":"Matthew S","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"271_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jcsm.12708","volume":"12","author":"F Amor","year":"2021","unstructured":"Amor F, Hong AV, Corre G, Sanson M, Suel L, Blaie S, Servais L, Voit T, Richard I, Israeli D (2021) Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy. J Cachexia, Sarcopenia Muscle 12:677\u2013693","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"271_CR2","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.3390\/ijms23042016","volume":"23","author":"N Bourg","year":"2022","unstructured":"Bourg N, Hong AV, Lostal W, Jaber A, Guerchet N, Tanniou G, Bordier F, Bertil-Froidevaux E, Georger C, Daniele N et al (2022) Co-administration of simvastatin does not potentiate the benefit of gene therapy in the mdx mouse model for Duchenne muscular dystrophy. Int J Mol Sci 23:2016","journal-title":"Int J Mol Sci"},{"key":"271_CR3","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.celrep.2015.07.066","volume":"12","author":"AA Fiorillo","year":"2015","unstructured":"Fiorillo AA, Heier CR, Novak JS, Tully CB, Brown KJ, Uaesoontrachoon K, Vila MC, Ngheim PP, Bello L, Kornegay JN et al (2015) TNF-\u03b1-induced microRNAs control dystrophin expression in Becker muscular dystrophy. Cell Rep 12:1678\u20131690","journal-title":"Cell Rep"},{"key":"271_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/srep05312","volume":"4","author":"T Horie","year":"2014","unstructured":"Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Nakazeki F, Ide Y et al (2014) MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo. Sci Rep 4:5312","journal-title":"Sci Rep"},{"key":"271_CR5","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.3390\/ijms25116108","volume":"25","author":"K Kie\u0142bowski","year":"2024","unstructured":"Kie\u0142bowski K, Bakinowska E, Procyk G, Zi\u0119tara M, Pawlik A (2024) The role of microRNA in the pathogenesis of Duchenne muscular dystrophy. Int J Mol Sci 25:6108","journal-title":"Int J Mol Sci"},{"key":"271_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2023.10.403","volume":"209","author":"PJ Koopmans","year":"2023","unstructured":"Koopmans PJ, Ismaeel A, Goljanek-Whysall K, Murach KA (2023) The roles of miRNAs in adult skeletal muscle satellite cells. Free Radic Biol Med 209:228\u2013238","journal-title":"Free Radic Biol Med"},{"key":"271_CR7","doi-asserted-by":"publisher","first-page":"921785","DOI":"10.3389\/fneur.2022.921785","volume":"13","author":"Q Meng","year":"2022","unstructured":"Meng Q, Zhang J, Zhong J, Zeng D, Lan D (2022) Novel miRNA biomarkers for patients with Duchenne muscular dystrophy. Front Neurol 13:921785","journal-title":"Front Neurol"},{"key":"271_CR8","doi-asserted-by":"crossref","unstructured":"Oikawa S, Akimoto T (2023) Functional analysis of microRNAs in skeletal muscle. In: Asakura A (ed) Skeletal muscle stem cells: methods and protocols. Springer US, New York, NY, pp 339\u2013349","DOI":"10.1007\/978-1-0716-3036-5_24"},{"key":"271_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.celrep.2017.10.023","volume":"21","author":"NL Price","year":"2017","unstructured":"Price NL, Rotllan N, Canfran-Duque A, Zhang X, Pati P, Arias N, Moen J, Mayr M, Ford DA, Baldan A et al (2017) Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis. Cell Rep 21:1317\u20131330","journal-title":"Cell Rep"},{"key":"271_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.1189862","volume":"328","author":"KJ Rayner","year":"2010","unstructured":"Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C (2010) MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328:1570\u20131573","journal-title":"Science"},{"key":"271_CR11","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/ijms25031469","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA (2024) Trials and tribulations of MicroRNA therapeutics. Int J Mol Sci 25:1469","journal-title":"Int J Mol Sci"},{"key":"271_CR12","doi-asserted-by":"crossref","unstructured":"Sowa N, Horie T, Ide Y, Baba O, Kora K, Yoshida T, Nakamura Y, Matsumura S, Matsushita K, Imanaka M et al (2025) MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration. EMBO Mol Med","DOI":"10.1038\/s44321-025-00273-9"},{"key":"271_CR13","doi-asserted-by":"publisher","first-page":"e80263","DOI":"10.1371\/journal.pone.0080263","volume":"8","author":"IT Zaharieva","year":"2013","unstructured":"Zaharieva IT, Calissano M, Scoto M, Preston M, Cirak S, Feng L, Collins J, Kole R, Guglieri M, Straub V et al (2013) Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular dystrophy. PLoS ONE 8:e80263","journal-title":"PLoS ONE"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00271-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00271-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00271-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:43:55Z","timestamp":1779065035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00271-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":13,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,11]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00271-x","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}